Consonance Capital Management LP / LEGN
Consonance Capital Management LP’s Legend Biotech Corp Position
Does Consonance Capital Management LP own Legend Biotech Corp (LEGN)? Not currently — the last reported position was 1.65M shares worth $68M in Q2 2021; the fund’s latest 13F (Q3 2022) no longer reports it.
Position Value
$68M
Q2 2021
Shares
1.65M
% of Portfolio
+8.14%
Quarters Held
2
position exited
Position History LEGN
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of LEGN.